Expertise in
2
conditions

Philippe Beuzeboc

Suresnes, FR 
Expertise in
2
conditions
Suresnes, FR 
OverviewLocationsClinical Research

Overview

Philippe Beuzeboc practices in Suresnes, France. Beuzeboc is highly rated in 2 conditions, according to our data. Their top areas of expertise are Prostate Cancer, HER2 Negative Breast Cancer, Bone Tumor, Orchiectomy, and Prostatectomy.

Their clinical research consists of co-authoring 124 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.

Locations

Suresnes, France
Other Locations
11, Rue Viète, Paris, 75017, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Randomized Multicenter, Phase III Trial Evaluating the Safety of 2 Schedules of Cabazitaxel (Bi-weekly Versus Tri-weekly) Plus Prednisone in Elderly Men (≥ 65years) With mCRPC Previously Treated With a Docetaxel-containing Regimen
Randomized Multicenter, Phase III Trial Evaluating the Safety of 2 Schedules of Cabazitaxel (Bi-weekly Versus Tri-weekly) Plus Prednisone in Elderly Men (≥ 65years) With mCRPC Previously Treated With a Docetaxel-containing Regimen
Enrollment Status: Completed
Publish Date: May 12, 2022
Intervention Type: Drug
Study Drugs: Cabazitaxel, Prednisone, Granulocyte colony-stimulating factor (G-CSF)
Study Phase: Phase 3

124 Total Publications

TROPHY-U-01, a phase II open-label study of sacituzumab govitecan in patients with metastatic urothelial carcinoma progressing after platinum-based chemotherapy and checkpoint inhibitors: updated safety and efficacy outcomes.
TROPHY-U-01, a phase II open-label study of sacituzumab govitecan in patients with metastatic urothelial carcinoma progressing after platinum-based chemotherapy and checkpoint inhibitors: updated safety and efficacy outcomes.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: September 28, 2023

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Beuzeboc's expertise for a condition
ConditionClose
      View All 8 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile